Key statistics
As of last trade, Day One Biopharmaceuticals Inc (DAWN:NSQ) traded at 13.50, 19.47% above the 52 week low of 11.30 set on Dec 01, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.31 |
---|---|
High | 13.58 |
Low | 13.28 |
Bid | 13.48 |
Offer | 13.51 |
Previous close | 13.34 |
Average volume | 1.08m |
---|---|
Shares outstanding | 100.85m |
Free float | 83.69m |
P/E (TTM) | -- |
Market cap | 1.35bn USD |
EPS (TTM) | -1.02 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 15:51 GMT.
More ▼
- Day One Announces Retirement of Dr. Samuel Blackman, Co-Founder and Head of Research & Development
- Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference
- Day One Reports Third Quarter 2024 Financial Results and Corporate Progress
- Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024
- Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
- Day One Announces Oversubscribed $175.0 Million Private Placement
- Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers
- Day One Announces Sale of Priority Review Voucher for $108 Million
- Day One Reports First Quarter 2024 Financial Results and Corporate Progress
- Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
More ▼